Arkolith/Insider Trading/SRNE/Form 4

Ji Henry

See Remarks, DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Dec 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2022Option exercise(X)300$5.50$2K500
Dec 2, 2022Option exercise(X)200$5.50$1K200

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 21, 2022Option exercise(X)3—$0195
Dec 2, 2022Option exercise(X)2—$0198

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-062586) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML